Vapotherm Inc (NYSE:VAPO) insider John Landry bought 3,000 shares of the company’s stock in a transaction dated Thursday, September 5th. The stock was bought at an average cost of $10.34 per share, with a total value of $31,020.00. Following the completion of the transaction, the insider now owns 97,703 shares in the company, valued at approximately $1,010,249.02. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website.
NYSE:VAPO opened at $8.70 on Thursday. The company has a 50-day moving average price of $13.80 and a 200-day moving average price of $17.74. Vapotherm Inc has a 12 month low of $8.30 and a 12 month high of $24.63. The company has a current ratio of 5.22, a quick ratio of 4.34 and a debt-to-equity ratio of 1.42. The stock has a market cap of $166.24 million and a price-to-earnings ratio of -0.63.
Vapotherm (NYSE:VAPO) last posted its earnings results on Monday, July 29th. The company reported ($0.76) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.81) by $0.05. The company had revenue of $11.99 million during the quarter, compared to analysts’ expectations of $11.90 million. Equities analysts forecast that Vapotherm Inc will post -3.07 EPS for the current fiscal year.
Several large investors have recently bought and sold shares of VAPO. Perceptive Advisors LLC lifted its position in shares of Vapotherm by 12.7% in the 2nd quarter. Perceptive Advisors LLC now owns 1,404,470 shares of the company’s stock worth $32,302,000 after purchasing an additional 158,155 shares during the period. Vanguard Group Inc. lifted its position in shares of Vapotherm by 60.2% in the 2nd quarter. Vanguard Group Inc. now owns 376,660 shares of the company’s stock worth $8,663,000 after purchasing an additional 141,539 shares during the period. Federated Investors Inc. PA lifted its position in shares of Vapotherm by 32.8% in the 1st quarter. Federated Investors Inc. PA now owns 398,435 shares of the company’s stock worth $7,829,000 after purchasing an additional 98,435 shares during the period. First Light Asset Management LLC lifted its position in shares of Vapotherm by 24.6% in the 2nd quarter. First Light Asset Management LLC now owns 496,969 shares of the company’s stock worth $11,430,000 after purchasing an additional 97,977 shares during the period. Finally, BlackRock Inc. lifted its position in Vapotherm by 24.7% during the 2nd quarter. BlackRock Inc. now owns 292,171 shares of the company’s stock valued at $6,719,000 after acquiring an additional 57,950 shares during the period. 50.85% of the stock is owned by hedge funds and other institutional investors.
Separately, Zacks Investment Research raised shares of Vapotherm from a “hold” rating to a “buy” rating and set a $18.00 target price for the company in a research report on Friday, August 2nd. Five investment analysts have rated the stock with a buy rating, The stock currently has an average rating of “Buy” and a consensus price target of $23.67.
Vapotherm Company Profile
Vapotherm, Inc, a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.
Read More: Cost of Debt
Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.